Selected research
Industry Research
Pharmaceutical Propellants Industry Research Report 2026
Market perspective
The global Pharmaceutical Propellants market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharmaceutical Propellants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharmaceutical Propellants is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Propellants is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharmaceutical Propellants include Yara International, The Linde Group, SRF, Solvay, DAIKIN Chemical, AlzChem and Akzo Nobel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmaceutical Propellants market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Propellants Market by Company
Yara International
The Linde Group
SRF
Solvay
DAIKIN Chemical
AlzChem
Akzo Nobel
Pharmaceutical Propellants Segment by Type
Liquefied Gases
Compressed Gases
Pharmaceutical Propellants Segment by Application
Asthma Sprays
Foam Sprays
Oral and Topical Sprays
Nasal Sprays
Pharmaceutical Propellants Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Propellants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Propellants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Propellants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharmaceutical Propellants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharmaceutical Propellants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharmaceutical Propellants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Liquefied Gases
- Compressed Gases
Applications
- Asthma Sprays
- Foam Sprays
- Oral and Topical Sprays
- Nasal Sprays
Companies covered
- Yara International
- The Linde Group
- SRF
- Solvay
- DAIKIN Chemical
- AlzChem
- Akzo Nobel
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pharmaceutical Propellants Market Size (2021-2032)
- 2.2.2 Global Pharmaceutical Propellants Sales (2021-2032)
- 2.2.3 Global Pharmaceutical Propellants Market Average Price (2021-2032)
- 2.3 Pharmaceutical Propellants by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Liquefied Gases
- 2.3.3 Compressed Gases
- 2.4 Pharmaceutical Propellants by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Asthma Sprays
- 2.4.3 Foam Sprays
- 2.4.4 Oral and Topical Sprays
- 2.4.5 Nasal Sprays
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharmaceutical Propellants Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pharmaceutical Propellants Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Pharmaceutical Propellants Revenue of Manufacturers (2021-2026)
- 3.4 Global Pharmaceutical Propellants Average Price by Manufacturers (2021-2026)
- 3.5 Global Pharmaceutical Propellants Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pharmaceutical Propellants, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pharmaceutical Propellants, Product Type & Application
- 3.8 Global Manufacturers of Pharmaceutical Propellants, Established Date
- 3.9 Global Pharmaceutical Propellants Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yara International
- 4.1.1 Yara International Company Information
- 4.1.2 Yara International Business Overview
- 4.1.3 Yara International Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yara International Pharmaceutical Propellants Product Portfolio
- 4.1.5 Yara International Recent Developments
- 4.2 The Linde Group
- 4.2.1 The Linde Group Company Information
- 4.2.2 The Linde Group Business Overview
- 4.2.3 The Linde Group Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 The Linde Group Pharmaceutical Propellants Product Portfolio
- 4.2.5 The Linde Group Recent Developments
- 4.3 SRF
- 4.3.1 SRF Company Information
- 4.3.2 SRF Business Overview
- 4.3.3 SRF Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SRF Pharmaceutical Propellants Product Portfolio
- 4.3.5 SRF Recent Developments
- 4.4 Solvay
- 4.4.1 Solvay Company Information
- 4.4.2 Solvay Business Overview
- 4.4.3 Solvay Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Solvay Pharmaceutical Propellants Product Portfolio
- 4.4.5 Solvay Recent Developments
- 4.5 DAIKIN Chemical
- 4.5.1 DAIKIN Chemical Company Information
- 4.5.2 DAIKIN Chemical Business Overview
- 4.5.3 DAIKIN Chemical Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DAIKIN Chemical Pharmaceutical Propellants Product Portfolio
- 4.5.5 DAIKIN Chemical Recent Developments
- 4.6 AlzChem
- 4.6.1 AlzChem Company Information
- 4.6.2 AlzChem Business Overview
- 4.6.3 AlzChem Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AlzChem Pharmaceutical Propellants Product Portfolio
- 4.6.5 AlzChem Recent Developments
- 4.7 Akzo Nobel
- 4.7.1 Akzo Nobel Company Information
- 4.7.2 Akzo Nobel Business Overview
- 4.7.3 Akzo Nobel Pharmaceutical Propellants Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Akzo Nobel Pharmaceutical Propellants Product Portfolio
- 4.7.5 Akzo Nobel Recent Developments
5 Global Pharmaceutical Propellants Market Scenario by Region
- 5.1 Global Pharmaceutical Propellants Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharmaceutical Propellants Sales by Region: 2021-2032
- 5.2.1 Global Pharmaceutical Propellants Sales by Region: 2021-2026
- 5.2.2 Global Pharmaceutical Propellants Sales by Region: 2027-2032
- 5.3 Global Pharmaceutical Propellants Revenue by Region: 2021-2032
- 5.3.1 Global Pharmaceutical Propellants Revenue by Region: 2021-2026
- 5.3.2 Global Pharmaceutical Propellants Revenue by Region: 2027-2032
- 5.4 North America Pharmaceutical Propellants Market Facts & Figures by Country
- 5.4.1 North America Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pharmaceutical Propellants Sales by Country (2021-2032)
- 5.4.3 North America Pharmaceutical Propellants Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pharmaceutical Propellants Market Facts & Figures by Country
- 5.5.1 Europe Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pharmaceutical Propellants Sales by Country (2021-2032)
- 5.5.3 Europe Pharmaceutical Propellants Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pharmaceutical Propellants Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pharmaceutical Propellants Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pharmaceutical Propellants Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pharmaceutical Propellants Market Facts & Figures by Country
- 5.7.1 South America Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pharmaceutical Propellants Sales by Country (2021-2032)
- 5.7.3 South America Pharmaceutical Propellants Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Pharmaceutical Propellants Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pharmaceutical Propellants Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pharmaceutical Propellants Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pharmaceutical Propellants Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pharmaceutical Propellants Sales by Type (2021-2032)
- 6.1.1 Global Pharmaceutical Propellants Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Pharmaceutical Propellants Sales Market Share by Type (2021-2032)
- 6.2 Global Pharmaceutical Propellants Revenue by Type (2021-2032)
- 6.2.1 Global Pharmaceutical Propellants Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pharmaceutical Propellants Revenue Market Share by Type (2021-2032)
- 6.3 Global Pharmaceutical Propellants Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pharmaceutical Propellants Sales by Application (2021-2032)
- 7.1.1 Global Pharmaceutical Propellants Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Pharmaceutical Propellants Sales Market Share by Application (2021-2032)
- 7.2 Global Pharmaceutical Propellants Revenue by Application (2021-2032)
- 7.2.1 Global Pharmaceutical Propellants Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pharmaceutical Propellants Revenue Market Share by Application (2021-2032)
- 7.3 Global Pharmaceutical Propellants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pharmaceutical Propellants Value Chain Analysis
- 8.1.1 Pharmaceutical Propellants Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pharmaceutical Propellants Production Mode & Process
- 8.2 Pharmaceutical Propellants Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pharmaceutical Propellants Distributors
- 8.2.3 Pharmaceutical Propellants Customers
9 Global Pharmaceutical Propellants Analyzing Market Dynamics
- 9.1 Pharmaceutical Propellants Industry Trends
- 9.2 Pharmaceutical Propellants Industry Drivers
- 9.3 Pharmaceutical Propellants Industry Opportunities and Challenges
- 9.4 Pharmaceutical Propellants Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst